Informatie:
Fout:
ID
21398
Beschrijving
NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: HLA-B*5701 Results Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV
Trefwoorden
Versies (1)
- 19-04-17 19-04-17 -
Geüploaded op
19 april 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Genetic Screening For HLA-B*5701 in Patients with HIV HLA-B*5701 Results NCT00340080
Genetic Screening For HLA-B*5701 HLA-B*5701 Results NCT00340080
- StudyEvent: ODM
Similar models
Genetic Screening For HLA-B*5701 HLA-B*5701 Results NCT00340080
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item
Does the subject want the option of receiving his or her HLA-B*5701 results when the results are available ?
text
C1514756 (UMLS CUI [1,1])
C0679560 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C0679560 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Code List
Does the subject want the option of receiving his or her HLA-B*5701 results when the results are available ?
CL Item
Yes (Y)
CL Item
No (N)